Imaging for early stage breast cancer

TARGIT: Confirmation trial

First patient in 2007, 935 at July 2013 19/30 center with Intrabeam

90% suitable for ASTRO Pre-pathology 79% IORT alone in 83%

IBTR at 23.3 months: 2.3%

Nodal Recurrence: 0.2% Contralateral breast: 0.9% Metastatic disease: 0.3%

Valente SA et al, Ann Surg Oncol 2016